Goldline Laboratories Private Limited
About Goldline Laboratories Private Limited
Data last updated:
Goldline Laboratories Private Limited is a public limited company based in New Delhi, Delhi, India. It operates in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 26 June 1990 and has been in existence for over 36 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U65910DL1990PLC391198.
The company has an authorised share capital of ₹85 Lakh and a paid-up capital of ₹73.24 Lakh. It is led by directors including Anuj Jindal and Ankush Goyal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 85 G T Karnal Road Industrial Area, New Delhi, Delhi, India – 110033.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.21 Cr, a growth of 91% compared to the previous year. For the same year it recorded a net profit of ₹67.57 Lakh (net margin 55.7%) and EBITDA of ₹1.02 Cr (EBITDA margin 84%). Revenue has declined at a compounded annual rate (CAGR) of 34% over three years and 30% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Goldline Laboratories has one previous CIN (Corporate Identification Number): U65910WB1990PLC049309. The current CIN is U65910DL1990PLC391198, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U65910DL1990PLC391198 | Current |
| U65910WB1990PLC049309 | Previous |
Contact details
Goldline Laboratories Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressB – 85 G T Karnal Road Industrial Area, New Delhi, Delhi, India – 110033
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
To see the full contact details of Goldline Laboratories Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Goldline Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Goldline Laboratories Private Limited, buy the company report.
Financials of Goldline Laboratories Private Limited
FY 2025 filings availableGoldline Laboratories Private Limited reported revenue of ₹1.21 Cr (up 91% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 91% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 30%. EBITDA rose 108% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.02 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹67.57 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 84% | ||||
| Net Profit Margin | 55.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Goldline Laboratories Private Limited, buy the company report.
Board of directors of Goldline Laboratories Private Limited
Goldline Laboratories has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anuj Jindal Also directs: Karwa Enterprises Private Limited, Deep Laboratories Private Limited, TLS Agros India Private Limited and 5 more | Director | 26 Sep 2008 | 18 Years 1 Months | Current |
| Ankush Goyal Also directs: Jagat Diagnostics Private Limited, Karwa Enterprises Private Limited, Onkar Laboratories Private Limited and 4 more | Director | 26 Sep 2008 | 18 Years 1 Months | Current |
| Nancy Jindal | Director | 15 Dec 2020 | 5 Years 10 Months | Current |
Peer comparison
Goldline Laboratories Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sampharm Labs Private Limited | ₹1.22 Cr (FY 2024) | 4.0% | Bangalore, Karnataka, India | |||
| Soulzh India Private Limited | ₹1.21 Cr (FY 2025) | 71.0% | Ambarnath, Maharashtra, India | |||
| Theertha Biopharma Private Limited | ₹1.21 Cr (FY 2024) | 219.0% | Bangalore, Karnataka, India | |||
| Pgu India Private Limited | ₹1.21 Cr (FY 2025) | 14656.0% | Ahmedabad, Gujarat, India | |||
| Unipact Pharmaceuticals Private Limited | ₹1.21 Cr (FY 2025) | -4.0% | Jabalpur, Madhya Pradesh, India | |||
| Goldline Laboratories Private Limitedthis company | ₹1.21 Cr (FY 2025) | ₹67.57 Lakh | 55.7% | 91.0% | New Delhi, Delhi, India | |
| Vrindha Biotech Private Limited | ₹1.21 Cr (FY 2025) | 23.0% | Roorkee, Uttarakhand, India | |||
| Athos Chemicals Private Limited | ₹1.21 Cr (FY 2024) | 532.0% | Surat, Gujarat, India | |||
| Kepking Pharma Private Limited | ₹1.21 Cr (FY 2025) | 28.0% | Surat, Gujarat, India | |||
| Jisha Herbal Extracts Private Limited | ₹1.21 Cr (FY 2025) | 1112.0% | Arcot, Tamil Nadu, India | |||
| Soor Colour Fresh Private Limited | ₹1.21 Cr (FY 2025) | -9.0% | Surat, Gujarat, India |
To see the full peer comparison of Goldline Laboratories Private Limited, buy the company report.
Auditor
Goldline Laboratories Private Limited is audited by SWEETKUMARBANSAL for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SWEETKUMARBANSAL | FY 2017 | 087043 |
Shareholding
The shareholding of Goldline Laboratories Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Goldline Laboratories Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Goldline Laboratories Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Goldline Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Goldline Laboratories has 1 associated company. This group structure data is as of FY 2017. The table lists each entity with its relationship and holding.
GST
No GST registration is on our record for Goldline Laboratories Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Goldline Laboratories Private Limited has 11 board changes on record since 2005: 7 appointments and 4 cessations. The latest: Lokesh Kumar Jindal ceased to be Director on 18 Dec 2020.
2 earlier events are in the company report.
Frequently asked questions
Goldline Laboratories is an active public limited company based in New Delhi, Delhi, India. The company works in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 26 June 1990 (36+ years old) and is registered under CIN U65910DL1990PLC391198.
Goldline Laboratories has 3 current directors:
- Anuj Jindal - Director
- Ankush Goyal - Director
- Nancy Jindal - Director
The latest financial statements of Goldline Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Goldline Laboratories is U65910DL1990PLC391198. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Goldline Laboratories was incorporated on 26 June 1990, making it 36+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Goldline Laboratories by revenue are Sampharm Labs Private Limited, Soulzh India Private Limited, Theertha Biopharma Private Limited, Pgu India Private Limited, Unipact Pharmaceuticals Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Lokesh Kumar Jindal ceased to be Director on 18 Dec 2020. Nancy Jindal was appointed as Director on 15 Dec 2020. Chiranjit Banerjee ceased to be Director on 13 Oct 2008. Goldline Laboratories has 11 board changes on record in total.
The registered office of Goldline Laboratories is at B – 85 G T Karnal Road Industrial Area, New Delhi, Delhi, India – 110033.
Goldline Laboratories operates in the chemicals industry, in the medicinal chemical and botanical products segment.
The compliance status of Goldline Laboratories is compliant as of 10 August 2026. The company is actively filing with the Registrar of Companies.
Goldline Laboratories can be reached at its registered office: B – 85 G T Karnal Road Industrial Area, New Delhi, Delhi, India – 110033.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
